FR3032352A1 - Composition cosmetique comprenant au moins une huile essentielle de petit grain bigarade et son utilisation - Google Patents
Composition cosmetique comprenant au moins une huile essentielle de petit grain bigarade et son utilisation Download PDFInfo
- Publication number
- FR3032352A1 FR3032352A1 FR1550898A FR1550898A FR3032352A1 FR 3032352 A1 FR3032352 A1 FR 3032352A1 FR 1550898 A FR1550898 A FR 1550898A FR 1550898 A FR1550898 A FR 1550898A FR 3032352 A1 FR3032352 A1 FR 3032352A1
- Authority
- FR
- France
- Prior art keywords
- skin
- cosmetic
- essential oil
- composition
- mucous membranes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 239000000341 volatile oil Substances 0.000 title claims abstract description 68
- 239000002537 cosmetic Substances 0.000 title claims abstract description 55
- 244000183685 Citrus aurantium Species 0.000 title claims description 37
- 235000007716 Citrus aurantium Nutrition 0.000 title claims description 36
- 210000004400 mucous membrane Anatomy 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 17
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 9
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 239000000839 emulsion Substances 0.000 claims description 9
- 230000004888 barrier function Effects 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 244000062730 Melissa officinalis Species 0.000 claims description 2
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 2
- 239000000865 liniment Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 206010001488 Aggression Diseases 0.000 claims 1
- 230000016571 aggressive behavior Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 30
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 20
- 235000016646 Citrus taiwanica Nutrition 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 210000002510 keratinocyte Anatomy 0.000 description 15
- 210000002615 epidermis Anatomy 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 13
- 150000002191 fatty alcohols Chemical class 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 102100028314 Filaggrin Human genes 0.000 description 8
- 101710088660 Filaggrin Proteins 0.000 description 8
- 230000004069 differentiation Effects 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 230000037365 barrier function of the epidermis Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000036571 hydration Effects 0.000 description 7
- 238000006703 hydration reaction Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000004224 protection Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000011712 cell development Effects 0.000 description 6
- 230000002787 reinforcement Effects 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 150000002194 fatty esters Chemical class 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 230000007248 cellular mechanism Effects 0.000 description 3
- 239000003241 dermatological agent Substances 0.000 description 3
- 229940000033 dermatological agent Drugs 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 210000000736 corneocyte Anatomy 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 2
- 230000008642 heat stress Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 101710082233 2,4-diaminopentanoate dehydrogenase Proteins 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- 244000003034 Arancio amaro Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000915384 Cinnamosma Species 0.000 description 1
- 235000002548 Cistus Nutrition 0.000 description 1
- 241000984090 Cistus Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000016840 Citrus aurantium var. amara Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 241000016649 Copaifera officinalis Species 0.000 description 1
- 244000166652 Cymbopogon martinii Species 0.000 description 1
- 108700041153 Filaggrin Proteins Proteins 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 101710141619 Meso-diaminopimelate D-dehydrogenase Proteins 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 229920003188 Nylon 3 Polymers 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000017304 Ruaghas Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229940073736 biosaccharide gum-4 Drugs 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940112262 ceteareth-2 phosphate Drugs 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (14)
- REVENDICATIONS1. Utilisation non thérapeutique d'une huile essentielle de Petit grain bigarade en tant qu'actif cosmétique.
- 2. Utilisation selon la revendication 1, dans laquelle ladite huile essentielle est obtenue à partir des feuilles et/ou petites tiges de Petit grain bigarade.
- 3. Utilisation selon la revendication 1, pour protéger la peau et/ou les muqueuses des agressions extérieures.
- 4. Utilisation selon la revendication 1 ou 2, pour hydrater la peau et/ou les muqueuses.
- 5. Utilisation selon la revendication 1 ou 2, pour nourrir la peau et/ou les muqueuses.
- 6. Utilisation selon l'une quelconque des revendications précédentes, pour renforcer la fonction barrière de la peau et/ou des muqueuses.
- 7. Utilisation selon l'une quelconque des revendications précédentes, pour améliorer l'éclat de la peau et/ou améliorer le teint de la peau et/ou homogénéiser le teint de la peau.
- 8. Composition cosmétique ou dermatologique comprenant une huile essentielle de Petit grain bigarade.
- 9. Composition selon la revendication 8, dans laquelle la concentration de l'huile essentielle est comprise de 0,0001% à 15% en poids par rapport au poids total de la composition.
- 10.Composition selon l'une quelconque des revendications 8 ou 9, ladite composition étant sous une forme choisie parmi un onguent, une crème, une huile, un lait, une pommade, une poudre, une solution, un gel, une lotion, une suspension, un baume et une émulsion.
- 11. UtilisatiOn cosmétique non thérapeutique de la composition selon l'une quelconque des revendications 8 à 10, pour protéger et/ou hydrater et/ou nourrir la peau et/ou les muqueuses.
- 12. Utilisation cosmétique non thérapeutique de la composition selon l'une quelconque des revendications 8 à 10, pour améliorer l'éclat de la peau et/ou améliorer le teint de la peau et/ou homogénéiser le teint de la peau. 3032352
- 13. Procédé de traitement cosmétique non thérapeutique comprenant l'application sur la peau ou les muqueuses d'une composition cosmétique ou dermatologique selon l'une quelconque des revendications 8 à 12.
- 14. Trousse pour le traitement cosmétique non thérapeutique de la peau ou des muqueuses comprenant une composition cosmétique ou dermatologique selon l'une quelconque des revendications 8 à 12 et un support comportant des instructions pour l'emploi de la composition sur la peau ou les muqueuses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1550898A FR3032352B1 (fr) | 2015-02-05 | 2015-02-05 | Composition cosmetique comprenant au moins une huile essentielle de petit grain bigarade et son utilisation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1550898 | 2015-02-05 | ||
FR1550898A FR3032352B1 (fr) | 2015-02-05 | 2015-02-05 | Composition cosmetique comprenant au moins une huile essentielle de petit grain bigarade et son utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3032352A1 true FR3032352A1 (fr) | 2016-08-12 |
FR3032352B1 FR3032352B1 (fr) | 2018-05-11 |
Family
ID=53541712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1550898A Active FR3032352B1 (fr) | 2015-02-05 | 2015-02-05 | Composition cosmetique comprenant au moins une huile essentielle de petit grain bigarade et son utilisation |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3032352B1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3744339A1 (fr) * | 2019-05-28 | 2020-12-02 | Chanel Parfums Beauté | Extrait fermente de parties aeriennes de neroli |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2425953A (en) * | 2005-04-25 | 2006-11-15 | Leslie Victor Wilmot | A lotion for overall body and skin protection |
FR3004347A1 (fr) * | 2013-04-11 | 2014-10-17 | Rocher Yves Biolog Vegetale | Composition cosmetique comprenant une huile essentielle de sauge et son utilisation |
-
2015
- 2015-02-05 FR FR1550898A patent/FR3032352B1/fr active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2425953A (en) * | 2005-04-25 | 2006-11-15 | Leslie Victor Wilmot | A lotion for overall body and skin protection |
FR3004347A1 (fr) * | 2013-04-11 | 2014-10-17 | Rocher Yves Biolog Vegetale | Composition cosmetique comprenant une huile essentielle de sauge et son utilisation |
Non-Patent Citations (5)
Title |
---|
C LASSERRE AND E TSCHACHLER: "Essential oil of neroli is a potent inhibitor of MMPs activities", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 121, no. 1, 0283, 30 May 2004 (2004-05-30) - 1 July 2003 (2003-07-01), pages 1 - 214, XP055054364, Retrieved from the Internet <URL:http://www.nature.com/jid/journal/v121/n1/pdf/5601861a.pdf> [retrieved on 20130222] * |
DATABASE GNPD [online] MINTEL; 1 August 2014 (2014-08-01), ODACITÉ: "Mo + P Moringa Petitgrain Very Dry Skin Facial Serum Concentrate", XP002751250, Database accession no. 2587423 * |
DATABASE GNPD [online] MINTEL; 1 January 2008 (2008-01-01), THIS WORKS: "Clean Skin for the Face Cleanser", XP002751252, Database accession no. 848927 * |
DATABASE GNPD [online] MINTEL; 1 January 2014 (2014-01-01), VITACOLOGY: "Hydro-Sensitive Cream with 5 Flowers", XP002751251, Database accession no. 2193295 * |
DATABASE GNPD [online] MINTEL; 1 July 2010 (2010-07-01), YVES ROCHER: "Night Cream (Culture Bio Night Cream)", XP002751253, Database accession no. 1361554 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3744339A1 (fr) * | 2019-05-28 | 2020-12-02 | Chanel Parfums Beauté | Extrait fermente de parties aeriennes de neroli |
US11331264B2 (en) | 2019-05-28 | 2022-05-17 | Chanel Parfums Beaute | Fermented extract of aerial parts of bitter orange |
Also Published As
Publication number | Publication date |
---|---|
FR3032352B1 (fr) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH696135A5 (fr) | Méthodes et formulations cosmétiques. | |
CA2461462A1 (fr) | Composition cosmetique pour le soin de la peau et des cheveux de l'homme | |
FR3018189A1 (fr) | Composition cosmetique / dermatologique comprenant au moins une huile essentielle de ciste et son utilisation | |
FR2998478A1 (fr) | Utilisation d'un melange d'huiles essentielles comme agent desquamant | |
FR3011183A1 (fr) | Utilisation d'une composition huileuse contenant un extrait d'hemerocalle pour ameliorer la fermete de la peau. | |
EP2291173B1 (fr) | Association d'extraits de passiflore et d'anchuse utilisable en cosmetique | |
FR3091162A1 (fr) | Utilisation cosmétique et/ou nutraceutique d'un extrait d'écorce d'Eperua falcata | |
FR3032352A1 (fr) | Composition cosmetique comprenant au moins une huile essentielle de petit grain bigarade et son utilisation | |
FR3082122A1 (fr) | Utilisation d'un extrait de bixa orellana | |
FR3004347A1 (fr) | Composition cosmetique comprenant une huile essentielle de sauge et son utilisation | |
FR3104436A1 (fr) | Composition cosmétique comprenant des extraits de grenadier et de pivoine | |
FR2960438A1 (fr) | Composition cosmetique - dermatologique comprenant au moins une huile essentielle et leur utilisation | |
FR3008890B1 (fr) | Extrait de chene, composition comprenant ledit extrait et utilisations notamment cosmetiques | |
KR101993324B1 (ko) | 피부 장벽 개선용 화장료 조성물 | |
FR3107834A1 (fr) | Utilisation d’une association d’huiles essentielles pour ameliorer la surface de la peau | |
FR2791887A1 (fr) | Compositions cosmetiques ou dermopharmaceutiques renfermant des extraits vegetaux de pinus lambertania contre la secheresse cutanee de toute origine | |
FR3056106A1 (fr) | Utilisation cosmetique d’une composition comprenant une eau thermale en association avec au moins deux autres agents actifs pour l’amelioration de l’aspect general de la peau | |
WO2020249382A1 (fr) | Utilisation cosmétique d'un extrait d'or végétal (syngonanthus nitens ruhland) | |
FR3034015A1 (fr) | Composition comprenant des fleurs sechees d'immortelle pour un usage cosmetique | |
FR2974511A1 (fr) | Composition cosmetique comprenant une huile essentielle de lavande et leur utilisation | |
FR3116727A1 (fr) | Composition comprenant une eau végétale de riz et une huile de son riz de Camargue et utilisations notamment en cosmétique | |
FR3021539A1 (fr) | Composition cosmetique et/ou dermatologique comprenant un extrait vegetal et un activateur de genes | |
FR3116728A1 (fr) | Eau végétale de riz de Camargue et utilisations notamment en cosmétique | |
FR3099992A1 (fr) | Utilisation cosmetique d'un extrait de sedum spectabile en tant agent amincissant, et compositions contenant un tel extrait | |
FR3107835A1 (fr) | Utilisation d’une association d’huiles essentielles pour une action anti-age sur la peau, ses annexes et/ou les muqueuses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20160812 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
TP | Transmission of property |
Owner name: STANHOME INTERNATIONAL, FR Effective date: 20170823 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
TP | Transmission of property |
Owner name: LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER, FR Effective date: 20230406 |
|
PLFP | Fee payment |
Year of fee payment: 10 |